|
所在平台: Udemy |
课程主页: https://www.udemy.com/course/the-essential-guide-to-pharmaceutical-market-access/
课程评论：没有评论
课程名称：制药市场准入的基本指南 概述：本课程深入探讨制药行业中的市场准入，重点关注成功将新药推向市场所需的基本策略和流程。学员将学习如何在复杂的定价和报销、健康技术评估（HTA）和药物流行经济学分析的世界中导航，这些都是确保患者获得治疗的关键组成部分。课程内容包括：PowerPoint笔记、视频、深入文章、测验等。 主要内容涵盖： 1. **市场准入策略**：学习设计和实施有效策略，以确保新药在不同地区的成功上市和报销。理解如何克服常见的准入障碍，并与利益相关者合作，达到最佳市场准入。 2. **健康技术评估（HTA）**：深入了解HTA流程，理解其在药物批准和报销中的作用。掌握HTA提交的准备工作，以及它们如何影响全球的市场准入决策。 3. **药物流行经济学模型**：培养构建成本效益、预算影响和成本效用模型的专业知识，以支持市场准入策略。了解如何应用这些模型向付款方和监管机构展示新疗法的价值。 4. **利益相关者参与**：获得与关键利益相关者（包括付款方、医疗提供者、监管机构和患者权益团体）沟通和影响的技能，以确保顺畅的报销和准入流程。 5. **真实世界证据（RWE）**：学习真实世界数据如何日益影响市场准入决策，从展示药物价值到确保报销。理解如何有效地将RWE整合到市场准入策略中。 6. **全球市场准入考虑**：了解市场准入策略如何针对不同地区的医疗保健系统和报销流程量身定制。学习北美、欧洲和新兴市场在确保药物准入时面临的独特挑战。 7. **知识测试**：课程结束时，您将有机会通过综合考试展示您的理解能力。此最终评估将复习和巩固整个课程中涉及的所有关键概念，确保您在继续学习之前对材料有扎实的掌握。 通过本课程，您将掌握必要的工具、框架和实用知识，以导航制药市场准入领域，确保新治疗方案的成功推出。
This course provides an in-depth exploration of Market Access within the pharmaceutical industry, focusing on the essential strategies and processes required to successfully bring new drugs to market. You'll learn to navigate the complex world of pricing and reimbursement, Health Technology Assessments (HTA), and pharmacoeconomic analysis, all critical components in securing access to treatments for patients. Included: PowerPoint notes, videos, in-depth articles, quizzes, and more!Key areas covered include:Market Access Strategy: Learn how to design and implement effective strategies to ensure the successful launch and reimbursement of new pharmaceuticals across different regions. Understand how to overcome common access barriers and work with stakeholders to achieve optimal market entry.Health Technology Assessments (HTA): Dive deep into HTA processes, understanding their role in shaping drug approval and reimbursement. Master the preparation of HTA submissions and learn how they impact market access decisions globally.Pharmacoeconomic Models: Develop expertise in building cost-effectiveness, budget impact, and cost-utility models to support your market access strategy. Understand how to apply these models to demonstrate the value of new therapies to payers and regulators.Stakeholder Engagement: Gain the skills necessary to engage with and influence key stakeholders, including payers, healthcare providers, regulators, and patient advocacy groups, to ensure smooth reimbursement and access processes.Real-World Evidence (RWE): Learn how real-world data is increasingly shaping market access decisions, from demonstrating the value of a drug to securing reimbursement. Understand how to effectively integrate RWE into your market access strategies.Global Market Access Considerations: Understand how market access strategies must be tailored to different regional healthcare systems and reimbursement processes. Learn the unique challenges of securing drug access in North America, Europe, and emerging markets.Test your knowledge: As this class concludes, you will have the opportunity to demonstrate your understanding through a comprehensive exam. This final assessment will review and reinforce all key concepts covered throughout the course, ensuring that you have a solid grasp of the material before moving forwardBy the end of the course, you'll be equipped with the essential tools, frameworks, and practical knowledge to navigate the pharmaceutical market access landscape and ensure the successful introduction of new treatments to the market.
